EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
+11.44%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.81B
AUM Growth
+$194M
(+12%)
Cap. Flow
+$44.6M
Cap. Flow
% of AUM
2.46%
Top 10 Holdings %
Top 10 Hldgs %
63.7%
Holding
392
New
24
Increased
176
Reduced
102
Closed
74
Top Buys
| 1 |
Futu Holdings
FUTU
|
$31.5M |
| 2 |
Applied Materials
AMAT
|
$29.1M |
| 3 |
Apple
AAPL
|
$15.5M |
| 4 |
Microsoft
MSFT
|
$12.6M |
| 5 |
NVIDIA
NVDA
|
$11.6M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
$28.5M |
| 2 |
TSMC
TSM
|
$15.1M |
| 3 |
KE Holdings
BEKE
|
$11.9M |
| 4 |
ASE Group
ASX
|
$7.99M |
| 5 |
Yum China
YUMC
|
$5.17M |
Sector Composition
| 1 | Consumer Discretionary | 39.73% |
| 2 | Technology | 31.74% |
| 3 | Communication Services | 9.52% |
| 4 | Healthcare | 5.08% |
| 5 | Financials | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Centene
CNC
$14.2B
| $219K | 0.01% |
3,309
+199
| +6% | +$13.2K |
|
277
Goldman Sachs
GS
$223B
| $219K | 0.01% |
484
-9
| -2% | -$4.07K |
|
278
Denali Therapeutics
DNLI
$2.26B
| $214K | 0.01% |
9,200
-11,352
| -55% | -$264K |
|
279
Dynavax Technologies
DVAX
$1.18B
| $213K | 0.01% |
18,929
-14,051
| -43% | -$158K |
|
280
Mettler-Toledo International
MTD
$26.9B
| $211K | 0.01% |
151
-18
| -11% | -$25.2K |
|
281
West Pharmaceutical
WST
$18B
| $209K | 0.01% |
634
+21
| +3% | +$6.92K |
|
282
Union Pacific
UNP
$131B
| $209K | 0.01% |
922
| – | – |
|
283
Zimmer Biomet
ZBH
$20.9B
| $208K | 0.01% |
1,917
+189
| +11% | +$20.5K |
|
284
AT&T
T
$212B
| $207K | 0.01% |
10,815
| – | – |
|
285
Teledyne Technologies
TDY
$25.7B
| $206K | 0.01% |
+532
| New | +$206K |
|
286
Steris
STE
$24.2B
| $206K | 0.01% |
939
+20
| +2% | +$4.39K |
|
287
ConocoPhillips
COP
$116B
| $204K | 0.01% |
1,782
| – | – |
|
288
Cardinal Health
CAH
$35.7B
| $202K | 0.01% |
2,054
+159
| +8% | +$15.6K |
|
289
Hologic
HOLX
$14.8B
| $202K | 0.01% |
2,715
+66
| +2% | +$4.9K |
|
290
RTX Corp
RTX
$211B
| $201K | 0.01% |
+2,007
| New | +$201K |
|
291
Novavax
NVAX
$1.28B
| $201K | 0.01% |
15,904
-63,610
| -80% | -$805K |
|
292
Agios Pharmaceuticals
AGIO
$2.09B
| $201K | 0.01% |
4,668
-5,785
| -55% | -$249K |
|
293
American Express
AXP
$227B
| $200K | 0.01% |
+865
| New | +$200K |
|
294
Viatris
VTRS
$12.2B
| $199K | 0.01% |
18,762
+2,275
| +14% | +$24.2K |
|
295
ADMA Biologics
ADMA
$4.03B
| $190K | 0.01% |
16,998
-15,243
| -47% | -$170K |
|
296
Recursion Pharmaceuticals
RXRX
$2.01B
| $181K | 0.01% |
24,165
-14,562
| -38% | -$109K |
|
297
Warner Bros
WBD
$30B
| $178K | 0.01% |
23,941
+538
| +2% | +$4K |
|
298
BioCryst Pharmaceuticals
BCRX
$1.74B
| $175K | 0.01% |
28,285
-45,895
| -62% | -$284K |
|
299
Catalyst Pharmaceutical
CPRX
$2.48B
| $175K | 0.01% |
11,266
-11,737
| -51% | -$182K |
|
300
ImmunityBio
IBRX
$2.27B
| $167K | 0.01% |
26,458
-35,464
| -57% | -$224K |
|